Your browser doesn't support javascript.
loading
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages.
Weidner, Lorraine; Lorenz, Julia; Quach, Stefanie; Braun, Frank K; Rothhammer-Hampl, Tanja; Ammer, Laura-Marie; Vollmann-Zwerenz, Arabel; Bartos, Laura M; Dekorsy, Franziska J; Holzgreve, Adrien; Kirchleitner, Sabrina V; Thon, Niklas; Greve, Tobias; Ruf, Viktoria; Herms, Jochen; Bader, Stefanie; Milenkovic, Vladimir M; von Baumgarten, Louisa; Menevse, Ayse N; Hussein, Abir; Sax, Julian; Wetzel, Christian H; Rupprecht, Rainer; Proescholdt, Martin; Schmidt, Nils O; Beckhove, Philipp; Hau, Peter; Tonn, Joerg-Christian; Bartenstein, Peter; Brendel, Matthias; Albert, Nathalie L; Riemenschneider, Markus J.
Afiliación
  • Weidner L; Department of Neuropathology, Regensburg University Hospital, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
  • Lorenz J; Department of Neuropathology, Regensburg University Hospital, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
  • Quach S; Wilhelm Sander Neuro-Oncology Unit, Regensburg University Hospital, Regensburg, Germany.
  • Braun FK; Department of Neurosurgery, University Hospital of Munich, LMU Munich, Munich, Germany.
  • Rothhammer-Hampl T; Department of Neuropathology, Regensburg University Hospital, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
  • Ammer LM; Department of Neuropathology, Regensburg University Hospital, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany.
  • Vollmann-Zwerenz A; Wilhelm Sander Neuro-Oncology Unit, Regensburg University Hospital, Regensburg, Germany.
  • Bartos LM; Department of Neurology, Regensburg University Hospital, Regensburg, Germany.
  • Dekorsy FJ; Department of Neurology, Regensburg University Hospital, Regensburg, Germany.
  • Holzgreve A; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
  • Kirchleitner SV; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
  • Thon N; Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.
  • Greve T; Department of Neurosurgery, University Hospital of Munich, LMU Munich, Munich, Germany.
  • Ruf V; Department of Neurosurgery, University Hospital of Munich, LMU Munich, Munich, Germany.
  • Herms J; Department of Neurosurgery, University Hospital of Munich, LMU Munich, Munich, Germany.
  • Bader S; Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.
  • Milenkovic VM; Center for Neuropathology and Prion Research, LMU Munich, Munich, Germany.
  • von Baumgarten L; Department of Psychiatry and Psychotherapy, University Regensburg, Regensburg, Germany.
  • Menevse AN; Department of Psychiatry and Psychotherapy, University Regensburg, Regensburg, Germany.
  • Hussein A; Department of Neurosurgery, University Hospital of Munich, LMU Munich, Munich, Germany.
  • Sax J; Division of Interventional Immunology, Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Wetzel CH; Division of Interventional Immunology, Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Rupprecht R; Division of Interventional Immunology, Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Proescholdt M; Department of Psychiatry and Psychotherapy, University Regensburg, Regensburg, Germany.
  • Schmidt NO; Department of Psychiatry and Psychotherapy, University Regensburg, Regensburg, Germany.
  • Beckhove P; Wilhelm Sander Neuro-Oncology Unit, Regensburg University Hospital, Regensburg, Germany.
  • Hau P; Department of Neurosurgery, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Tonn JC; Wilhelm Sander Neuro-Oncology Unit, Regensburg University Hospital, Regensburg, Germany.
  • Bartenstein P; Department of Neurosurgery, University Hospital Regensburg, 93053, Regensburg, Germany.
  • Brendel M; Division of Interventional Immunology, Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Albert NL; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Riemenschneider MJ; Wilhelm Sander Neuro-Oncology Unit, Regensburg University Hospital, Regensburg, Germany.
Acta Neuropathol Commun ; 11(1): 147, 2023 09 11.
Article en En | MEDLINE | ID: mdl-37697350
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Células Madre Mesenquimatosas / Glioma Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Acta Neuropathol Commun Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma / Células Madre Mesenquimatosas / Glioma Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Acta Neuropathol Commun Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido